Acne papulopustulos
Conditions
Interventions
Trade Name: Differin Gel
Product Name: Differin Gel
Product Code: 27599.00.01
Pharmaceutical Form: Gel
Sponsors
Technische Universität Dresden
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age >= 14 years Mild to moderate acne papulopustulosa according to Burton Scale Stage 3 to 4 At least 5 inflammatory and 5 non-inflammatory lesions in the face Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Pregnant and nursin women Antiandrogen therapy Therapy with antibiotics within the last 4 weeks Therapy with retinoids within the last 6 months. Natural or artificial UV-therapy within the last 4 weeks Severe acne papulopustulosa according to Burton Scale 5 or 6 Severe systemic condition Alcohol or drug abuse Noncompliant patients Use of other acne therapeutics 2 weeks before and during the study Secondyry acne (for example chlor and steroid acne)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Control of the effectiveness of visible light in combination with infrared light compared to Adapalen (Differin Gel);Secondary Objective: ;Primary end point(s): Reduction of inflammatory and non-inflammatory lewsions within 8 weeks after start of therapy. | — |
Countries
Germany
Outcome results
None listed